Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
Public ClinicalTrials.gov record NCT00583128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
Study identification
- NCT ID
- NCT00583128
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ocera Therapeutics
- Industry
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Interventions
- AST-120 Drug
- Celphere® CP-305 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Apr 30, 2010
- Completion
- May 31, 2010
- Last update posted
- Jun 17, 2014
2007 – 2010
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Associates | Huntsville | Alabama | 35801 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| Madeleine DuPree, MD | Boynton Beach | Florida | 33436 | — |
| Michael Epstein, MD | Annapolis | Maryland | 21401 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Long Island Gastrointestinal Research Group | Great Neck | New York | 11023 | — |
| LeBauer Research Associates | Greensboro | North Carolina | 27403 | — |
| Peters Medical Research, LLC | High Point | North Carolina | 27262 | — |
| Ohio Gastroenterology and Liver Institute | Cincinnatti | Ohio | 45219 | — |
| Oklahoma Foundation for Digestive Disease | Oklahoma City | Oklahoma | 73104 | — |
| Breco Research LTD | Houston | Texas | 77024 | — |
| Wisconsin Center for Advanced Research | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00583128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2014 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00583128 live on ClinicalTrials.gov.